These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 19080992

  • 1. [Generics in psychiatry--do they have the same therapeutic equivalence as the original?].
    Kasper S, Lentner S.
    Neuropsychiatr; 2008; 22(4):221-2. PubMed ID: 19080992
    [No Abstract] [Full Text] [Related]

  • 2. Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective.
    Emanuele E.
    South Med J; 2011 Oct; 104(10):715-6. PubMed ID: 21941163
    [No Abstract] [Full Text] [Related]

  • 3. Generics almost always a better choice.
    Johns Hopkins Med Lett Health After 50; 2009 Feb; 20(12):6-7. PubMed ID: 19241612
    [No Abstract] [Full Text] [Related]

  • 4. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC.
    J Clin Psychiatry; 2001 Feb; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [Abstract] [Full Text] [Related]

  • 5. The effectiveness of generic agents in psychopharmacologic treatment.
    Kumet R, Gelenberg AJ.
    Essent Psychopharmacol; 2005 Feb; 6(2):104-11. PubMed ID: 15765794
    [Abstract] [Full Text] [Related]

  • 6. Generic psychotropic medications: issues of cost-effectiveness and patient benefit.
    Ladue L.
    South Med J; 2011 Oct; 104(10):711-4. PubMed ID: 21941162
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost of treatment as a placebo effect in psychopharmacology: importance in the context of generic drugs.
    Andrade C.
    J Clin Psychiatry; 2015 Apr; 76(4):e534-6. PubMed ID: 25919852
    [Abstract] [Full Text] [Related]

  • 10. [Generics as therapeutic resources].
    Riverro-Serrano O, Juan-Lopez M, Lerdo-de Tejada F, Montoya-Cabrera MA, Camacho-Solís R, Valenzuela-Gomez Gallardo F, Lifshitz A, Gamboa-Marrufo J, Martínez-Domínguez M.
    Gac Med Mex; 1998 Apr; 134(2):169-206. PubMed ID: 9618996
    [No Abstract] [Full Text] [Related]

  • 11. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses.
    Donohue JM.
    Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937
    [No Abstract] [Full Text] [Related]

  • 12. Switching from brand-name to generic psychotropic medications: a literature review.
    Desmarais JE, Beauclair L, Margolese HC.
    CNS Neurosci Ther; 2011 Dec; 17(6):750-60. PubMed ID: 21114789
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Generic substitution for psychotropic drugs.
    Blier P.
    CNS Spectr; 2009 Sep; 14(9 Suppl Q and A Forum):1-7. PubMed ID: 20085109
    [No Abstract] [Full Text] [Related]

  • 15. Regulatory and clinical aspects of psychotropic medicinal products bioequivalence.
    Bałkowiec-Iskra E, Cessak G, Kuzawińska O, Sejbuk-Rozbicka K, Rokita K, Mirowska-Guzel D.
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1027-34. PubMed ID: 25858104
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.